• Articles
    • Latest Articles
    • Commentaries
    • Deals
    • Distillery
    • Emerging Companies
    • Finance
    • Politics, Policy & Law
    • Product Development
    • Regulation
    • Targets & Mechanisms
    • Tools & Techniques
  • Current Editions
  • Search Archives
  • BCIQ
    • Company Profiles
    • Target Profiles
    • Product Profiles
  • Conferences
    • China Healthcare Summit
    • Bio€quity Europe
  • White Papers
  • Free Trial / Subscribe
  • Sign In
Biocentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Free Trial Information
  • Pipeline
  • Deals
  • Financings
  • Articles
BioCentury | Mar 14, 2011
Company News

Gamma Therapeutics, Health Diagnostic Laboratory deal

...will be marketed by HDL. The assay is based on the naturally occurring clotting protein gamma prime fibrinogen...
Read More
Items per page:
10
1 - 1 of 1
Products & Solutions
  • Latest Articles
  • Products Overview
  • 简体中文
  • 日本語
  • 한국어
  • BCIQ
  • Conferences
  • White Papers
About Biocentury
  • Company Overview
  • Management
  • Editorial & Research
  • Scientific Advisory Board
Contact
  • Contact Us
  • Advertising & Sponsorship
  • Reprints & Permissions
  • Career Opportunities
  • Forgot Password
Privacy & Legal
  • User Agreement
  • Terms of Use
  • Privacy Policy
  • Your California Privacy Rights
  • Use of Images
  • Market data
  • Follow Us

    TwitterLinkedInRSS

© 2021 BioCentury Inc. All Rights Reserved.    Terms & Conditions | Privacy Policy

Previous page
Next page